SCHEMBL7598085

SCHEMBL7598085

O=C(O)C(=Cc1cccc(O)c1)C(=O)C=Cc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 6/20 0.51
MMP2 P08253 6/20 0.51
MMP9 P14780 6/20 0.51
KDM4E B2RXH2 2/20 0.50
MAOA P21397 1/20 0.49
MAOB P27338 1/20 0.49
HSP90AA1 P07900 1/20 0.49
AKR1B10 O60218 1/20 0.47
AKR1B1 P15121 1/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP3A4 P08684 1/20 0.47
MAPT P10636 1/20 0.47
THRB P10828 1/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HSD17B10 Q99714 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16670788 0.95 MMP1 (0.52) MMP1MMP2MMP9KDM4EMAOA
SCHEMBL11126196 0.85 MAPT (0.55) MMP1MMP2MMP9MAOAMAOB
SCHEMBL6381221 0.84 KDM4E (0.62) MMP1MMP2MMP9KDM4EMAOA
SCHEMBL7584015 0.79 TYR (0.58) MMP1MMP2MMP9KDM4EMAOA
SCHEMBL28435739 0.78 MAPT (0.59) MMP1MMP2MMP9MAOAMAOB
SCHEMBL9416654 0.78 MAPT (0.59) MMP1MMP2MMP9MAOAMAOB
SCHEMBL27541702 0.78 KMT2A (0.54) MAOBALDH1A1MAPTKMT2ASMN1; SMN2
SCHEMBL30938425 0.78 KDM4E (0.55) KDM4EALDH1A1CYP3A4MAPTTDP1
SCHEMBL7551989 0.78 KDM4E (0.55) KDM4EALDH1A1CYP3A4MAPTTDP1
SCHEMBL31634782 0.78 KDM4E (0.55) KDM4EALDH1A1CYP3A4MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1263454-A2 METHODS FOR ENHANCING THE BIOAVAILABILITY OF A DRUG Praecis Pharmaceuticals Incorporated (US) 2002-12-11 EP disclosed
WO-2001058470-A2 METHODS FOR ENHANCING THE BIOAVAILABILITY OF A DRUG PRAECIS PHARMACEUTICALS INCORPORATED (US) 2001-08-16 WO disclosed